ASTRAZENECA PHAMACEUTICALS LP | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for ASTRAZENECA PHAMACEUTICALS LP

Sort by

Viewing results 1‒25 of 52

Due Diligence
Nelson Peltz’s plan to halt the banking crisis Premium content
...News round-up GAM board recommends £96mn takeover offer from Liontrust (FT) AstraZeneca chair says it is paying CEO enough to ward off US rivals (FT) Oaktree Capital’s Howard Marks to undergo cancer treatment...
May 5, 2023
Due Diligence
Private equity and the art of Chinese diplomacy Premium content
...Deutsche Wohnen investor seeks injunction to block capital increase (FT) Veritas, Elliott consider $20bn-plus Athenahealth sale (Bloomberg) GE announces biggest acquisition under CEO Culp (Reuters) AstraZeneca...
September 24, 2021
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
LexTakeda Pharmaceutical Co Ltd
Takeda/Blackstone: eschewing gum Premium content
...With the stock trading at more than 42 times forward earnings, a premium of nearly 70 per cent to global peers like AstraZeneca, further gains are likely to be limited....
August 19, 2020
LombardMatthew Vincent
Woodford finds all is not lost — and there’s hope on the Horizon
...Its Crispr gene-editing technique has earned it an agreement with AstraZeneca and another unnamed “major” pharmaceutical company — and this is an end-market with a compound annual growth rate of 15-20 per...
September 17, 2018
Pharmaceuticals sector
Roche boosted by haemophilia and cancer trials; shares in rivals slip
...AstraZeneca fell 0.5 per cent. Photo: Bloomberg...
November 20, 2017
fastFTJoel Lewin
Sterling advance cools FTSE 100
...Leading the losses are the dollar earning miners and pharmaceutical groups that have benefited so handsomely from the weakness of the pound, with Fresnillo down 2 per cent, Astrazeneca off 1.7 per cent and...
July 12, 2016
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
Capital markets
‘Almost madness’: Companies pile into euro bonds
...AstraZeneca has set initial price guidance at 0.5 per cent to 0.55 per cent for its 5-year bond, while both AstraZeneca and Shell are both looking to pay about 1.5 per cent to borrow for 12 years....
May 9, 2016
Mergers & Acquisitions
Medivation hires bankers to defend against takeover
...Other potential drugmakers who could be interested in acquiring Medivation include AstraZeneca and Roche....
March 30, 2016
FT AlphavilleChris Nuttall
FT Opening Quote
...AstraZeneca has received Japanese marketing approval for the use of its Tagrisso drug for treating some forms of non-small cell lung cancer....
March 29, 2016
US & Canadian companies
Taubman lures more dealmakers to boutique
...named co-head of Emea healthcare at JPMorgan in early 2014 and has been involved in some of the largest healthcare transactions since then – including US drugmaker Pfizer’s attempted takeover of the UK’s AstraZeneca...
April 29, 2015
US & Canadian companies
Ackman gains ground in fight to force Allergan to sell to Valeant
...Now that Abbvie’s £35bn bid for Shire has collapsed and the chances of Pfizer making a fresh £69bn bid for AstraZeneca have greatly diminished, it is also the sector’s biggest potential deal of the year....
November 4, 2014
Business blogJohn Gapper
Pfizer, AstraZeneca and the UK as an offshore tax base
...Pfizer is making the most of this aspect of its proposed takeover of AstraZeneca, in order to play down the reality that it would be a US takeover of a UK company....
April 28, 2014
LombardJonathan Guthrie
Viking raiders will bring Norse sense to company votes
...It accordingly takes regular pops at US bank bosses, such as Lloyd Blankfein of Goldman Sachs, and has sent the likes of AstraZeneca away with fleas in their ears on pay....
August 7, 2014
US & Canadian companies
Zimmer agrees $13.4bn Biomet acquisition
...There have also been leaks of talks – since abandoned – between Pfizer and AstraZeneca over a possible $100bn takeover....
April 24, 2014
FT AlphavilleMergers & Acquisitions
The (early) Lunch Wrap
...Pfizer raises bid for AstraZeneca to £50 per share. The move steps up pressure on the UK pharmaceuticals group to agree to a deal that would create the world’s biggest drugs company....
May 2, 2014
FT Live
FTWeekend Festival
Where the FT Weekend paper comes to life
Saturday, 7 September London, UK
FT AlphavilleMergers & Acquisitions
The (early) Lunch Wrap
...NEWS AstraZeneca turns down “final” £69bn offer from Pfizer, shares drop 12 per cent....
May 19, 2014
FT AlphavilleEuropean banks
The (early) Lunch Wrap
...Shares of Alstom were suspended from trading in Paris today (Bloomberg) Shareholders at AstraZeneca have revolted against pay proposals for top executives....
April 25, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) Pfizer, the US pharmaceuticals group, has renewed its interest in a takeover of UK rival AstraZeneca, in what would be one of the global drugs industry’s largest ever deals....
April 28, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...US political criticism of Pfizer’s bid for AstraZeneca ramped up late last week, partly as a result of concern in Maryland and Delaware – but also heightened attention from lawmakers worried about the tax...
May 13, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...(Reuters) AstraZeneca urges David Cameron to be neutral over Pfizer’s £63bn takeover bid: Leif Johansson, AstraZeneca’s Swedish chairman, cautioned the UK prime minister that the government’s active engagement...
May 6, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) On the first of two days of parliamentary hearings, Pfizer acknowledged that its proposed £63bn takeover of AstraZeneca will lead to job cuts and a fall in research and development spending...
May 14, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...The UK-listed drugmaker is the third FTSE 100 healthcare company to be targeted by a US rival so far this year after AstraZeneca fought off Pfizer and Smith & Nephew attracted tentative interest from Stryker...
June 23, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) Pfizer‘s chief executive flew into London on Tuesday to urge ministers to back its proposed £60bn takeover of AstraZeneca which he said would create a scientific powerhouse with a big...
April 30, 2014
FT AlphavilleMergers & Acquisitions
The (early) Lunch Wrap
...AstraZeneca is to buy out US partner Bristol-Myers Squibb from the pharmaceutical groups’ diabetes drug alliance in a deal worth up to $4.1bn....
December 19, 2013
FT AlphavilleEU energy
The 6am Cut London
...Lloyds, Shell, BAE Systems, AstraZeneca reporting....
August 1, 2013

Previous pagePage 1 of 3Next page